Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sufentanil dose on the effective induction dose of ciprofol in non-elderly adults
ChiCTR2600135555Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Fuyang District, Hangzhou
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and sufentanil (3 arms), sponsored by The First People's Hospital of Fuyang District, Hangzhou. Primary endpoint: ED50 of ciprofol for BIS < 60 within 5 minutes. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ciprofolsufentanil
Beyond the preview
Go deeper on ChiCTR2600135555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135555.